PortfoliosLab logoPortfoliosLab logo
FIAC vs. AMLX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FIAC vs. AMLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Focus Impact Acquisition Corp. (FIAC) and Amylyx Pharmaceuticals, Inc. (AMLX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


FIAC

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

AMLX

1D
-0.68%
1M
-19.81%
YTD
9.27%
6M
-7.11%
1Y
157.81%
3Y*
-19.37%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

FIAC vs. AMLX - Yearly Performance Comparison


2026 (YTD)2025202420232022
FIAC
Focus Impact Acquisition Corp.
0.00%0.00%-81.54%6.97%2.83%
AMLX
Amylyx Pharmaceuticals, Inc.
9.27%219.58%-74.32%-60.16%104.48%

Correlation

The correlation between FIAC and AMLX is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (3Y)
Calculated over the trailing 3-year period

0.00

Correlation (All Time)
Calculated using the full available price history since Jan 10, 2022

0.01

Fundamentals

Market Cap

FIAC:

$8.56M

AMLX:

$1.46B

EPS

FIAC:

-$1.66

AMLX:

-$1.55

Total Revenue (TTM)

FIAC:

$18.31K

AMLX:

$0.00

Gross Profit (TTM)

FIAC:

$6.96K

AMLX:

-$20.10M

EBITDA (TTM)

FIAC:

-$5.47M

AMLX:

-$150.30M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FIAC vs. AMLX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FIAC

AMLX
AMLX Risk / Return Rank: 8989
Overall Rank
AMLX Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
AMLX Sortino Ratio Rank: 9090
Sortino Ratio Rank
AMLX Omega Ratio Rank: 8585
Omega Ratio Rank
AMLX Calmar Ratio Rank: 9191
Calmar Ratio Rank
AMLX Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FIAC vs. AMLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Focus Impact Acquisition Corp. (FIAC) and Amylyx Pharmaceuticals, Inc. (AMLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

FIAC vs. AMLX - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


FIACAMLXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.37

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.08

Drawdowns

FIAC vs. AMLX - Drawdown Comparison


Loading charts...

Drawdown Indicators


FIACAMLXDifference

Max Drawdown

Largest peak-to-trough decline

-96.04%

Max Drawdown (1Y)

Largest decline over 1 year

-30.61%

Max Drawdown (3Y)

Largest decline over 3 years

-93.83%

Current Drawdown

Current decline from peak

-67.75%

Average Drawdown

Average peak-to-trough decline

-59.36%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.52%

Volatility

FIAC vs. AMLX - Volatility Comparison


Loading charts...

Volatility by Period


FIACAMLXDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.15%

Volatility (6M)

Calculated over the trailing 6-month period

41.86%

Volatility (1Y)

Calculated over the trailing 1-year period

66.96%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

91.49%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

91.49%

Dividends

FIAC vs. AMLX - Dividend Comparison

Neither FIAC nor AMLX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

FIAC vs. AMLX - Financials Comparison

This section allows you to compare key financial metrics between Focus Impact Acquisition Corp. and Amylyx Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M100.00M20222023202420252026
7.04K
0
(FIAC) Total Revenue
(AMLX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


FIAC and AMLX have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for FIAC and AMLX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer